The global biotechnology market was valued at USD 1.5 trillion and is projected to reach a market size of USD 3.53 trillion by the end of 2030. Over the forecast period of 2024–2030, the market is projected to grow at a CAGR of 13%.
Biotechnology is a multidisciplinary discipline that uses the natural sciences and engineering to generate products and services using organisms and their components. Hungarian engineer Károly Ereky coined the phrase in 1919 to refer to the process of turning raw materials into products by employing living organisms. The fundamental idea behind biotechnology is the utilization of biological systems and species, such as bacteria, yeast, and plants, to carry out certain functions or generate useful materials. This field gained prominence in the '90s due to the development of insulin and a better understanding of DNA. Additionally, the human genome project that was completed in 2003 helped in gaining better insights into personalized medicine and genomics. Presently, the market is emerging due to its focus on agriculture and medicine. In the future, with better investments and R&D activities, immense growth is anticipated.
Key Market Insights:
The Indian biotechnology sector was estimated to be worth around 92 billion dollars in 2023. By 2030, the sector was predicted to have a $300 billion market value.
With a turnover of more than six billion euros, Spanish biopharmaceutical producer Grifols ranked among the biggest biotechnology corporations in 2022.
The majority of the projected 436 billion dollars in worldwide biotech medicine sales are produced in the United States and Europe, which are the core biotech sector areas.
With a market valuation of $268.27 billion, Swiss biotech corporation Roche ranked as the world's largest biotech business in November 2022.
Compounds can fail in the final stage by 40%, the intermediate stage by 60%, and the preliminary stage by up to 36%. To tackle this problem, businesses must invest in high-throughput screening technologies for the accurate identification of compounds with desirable properties. Additionally, AI and ML can be used to generate algorithms for predicting efficacy at early stages.
Biotechnology Market Drivers:
Demand for personalized medicine has been facilitating the expansion.
Personalized medicine involves the concept of inventing treatments based on the genetic makeup of an individual. For this, factors like genes, environment, and lifestyle are considered. Customizing medical interventions to the distinct genetic composition of each patient can increase treatment effectiveness, reduce adverse effects, and improve patient care. Because biotechnology has made methods for analyzing and interpreting genetic and molecular data available, it has aided individualized therapy. This enables scientists to find genetic variants and mutations linked to illnesses, which can assist medical practitioners in forecasting treatment reactions, prognosis, and disease susceptibility. High-throughput screening technologies stem cell research, and AI & ML are being used to screen genetic data for the identification of new therapeutic agents. Drugs are developed accordingly.
Advancements in gene editing technologies have been boosting the market.
A set of tools called gene editing, often referred to as genome editing or genome engineering, enables researchers to specifically alter an organism's DNA. These technologies function like scissors to cut and then replace DNA, adding, removing, or changing it at particular places in the genome. Researchers are looking at gene therapies as a possible treatment for cancer, infectious illnesses, and genetic disorders and to create vaccines. In research mouse models, CRISPR has been utilized to fix mutations in genes that cause hereditary tyrosinemia, cataracts, hemophilia, inherited Duchenne muscular dystrophy, cystic fibrosis, and severe combined immunodeficiency. Mutations in the BRCA1 and BRCA2 genes, for example, can cause cancer. However, these mutations can be corrected by genome editing. Besides healthcare, CRISPR has been used for agricultural applications. It is possible to modify crops to generate fewer allergies. Wheat strands without gluten were created using CRISPR, making it suitable for those with celiac disease. Many such industrial applications are being researched to create advanced products for the benefit of humankind.
Biotechnology Market Restraints and Challenges:
Ethical concerns, cost constraints, and bioterrorism are the main issues that the market is currently facing.
The field of biotechnology raises social concerns about technologies like gene manipulation, cloning, and the use of animals for testing. This can create diminished biodiversity for species and crops. In the long run, the consequences are unknown. Additionally, transgenic organisms can be released into the environment, creating serious repercussions. Secondly, high initial investments are vital. This field requires advanced technologies, infrastructure, and other resources. Research and developmental activities have an equal probability of failure. Most of the clinical trials for diseases like cancer and diabetes fail during scrutiny. Thirdly, concerns are raised about the misuse of technologies. Terrorism involving the deliberate release or spread of biological agents is known as bioterrorism. The intentional introduction of viruses, bacteria, or other germs (agents) intended to sicken or kill humans, animals, or plants is known as a bioterrorism assault. This can put the countries at risk.
Biotechnology Market Opportunities:
Biotechnology provides many opportunities in various sectors. One such field is the environment. Environmental biotechnology is a branch of science that develops and applies biological systems and live creatures to solve environmental issues such as pollution, waste management, renewable energy production, and biodiversity preservation. Bio-based fossil fuels, bioplastics, biochemicals, biological enzymes that help in cleaning contaminants, and bioremediation techniques where organisms are introduced to digest certain chemicals and remove toxins are a few such breakthroughs. Secondly, agricultural biotechnology is another emerging field. By using gene editing tools, crops can be altered to have more resistance to pesticides, drought, allergens, and other environmental factors. GMO crops have been gaining prominence. Their nutritional profile is enhanced for better human health. Thirdly, biopharmaceuticals are becoming beneficial. They are sophisticated medications derived from live cells or creatures. They can be produced from biological sources, such as bacteria and filamentous fungi, or extracted from semisynthesized forms. Biopharmaceuticals seldom have adverse effects since they only target particular molecules. When compared to traditional medications, biopharmaceuticals show a high level of activity. For individuals who do not respond well to conventional synthetic medications, biopharmaceuticals can help. Furthermore, bioinformatics tools are being looked upon. Bioinformatics, an interdisciplinary scientific area, creates software tools and methods for interpreting biological data, particularly complicated and large-scale data sets. These tools help in predicting protein structure, developing drugs, understanding the genes that cause a certain illness, and proteomics.
BIOTECHNOLOGY MARKET REPORT COVERAGE:
|
REPORT METRIC |
DETAILS |
|
Market Size Available |
2023 - 2030 |
|
Base Year |
2023 |
|
Forecast Period |
2024 - 2030 |
|
CAGR |
13% |
|
Segments Covered |
By Technology, Application, and Region |
|
Various Analyses Covered |
Global, Regional & Country Level Analysis, Segment-Level Analysis, DROC, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities |
|
Regional Scope |
North America, Europe, APAC, Latin America, Middle East & Africa |
|
Key Companies Profiled |
Amgen Inc., Gilead Sciences, Inc., Biogen Inc., Genentech (Roche), Regeneron Pharmaceuticals Inc., Moderna Inc., Vertex Pharmaceuticals, Inc., CSL Limited, Novozymes A/S, Illumina Inc. |
Nanobiotechnology
Tissue Engineering and Regeneration
DNA Sequencing
Cell-based Assays
Fermentation
PCR Technology
Chromatography
Others
DNA sequencing is the largest growing technology. The technique of figuring out the nucleotide order in DNA is called DNA sequencing. This data is crucial for research in biology. One essential method for classifying and distinguishing terrestrial life forms is DNA sequencing. Understanding human genomic diversity and the genetic components of some disorders is also dependent on it. Secondly, DNA sequences from healthy and mutant samples may be compared to aid in the diagnosis of illnesses like cancer and to direct patient therapy. Sequencing, for instance, can be used to find inherited variations linked to a particular characteristic, vulnerability, or illness. By identifying alterations in certain genomic regions, it can also assist scientists in understanding how particular diseases arise. Additionally, virology, biological systematics, biotechnology, and forensic biology all depend on DNA sequencing. Nanobiotechnology is the fastest-growing segment. The science of nanotechnology is expanding quickly, and it may be used with biotechnology to aid in the diagnosis, treatment, and tracking of illnesses. This combination, known as bionanotechnology, can enhance pharmacological therapy, save costs, and improve medical results. Cancer diagnostics, complex disease therapies, personalized medicine, early-warning tests, and lab-on-a-chip technologies are a few biotechnology uses of nanotechnology. Nucleic acid therapies can also be delivered to immune cells and tumors with the use of nanotechnology.
Health
Food & Agriculture
Natural Resources & Environment
Industrial Processing
Bioinformatics
Others
The largest growing application is the health sector. Biotechnology applications are used for the production of vitamins, toxins, enzymes, hormones (including insulin and interferon), antibiotics, and more. Genetic illness diagnosis is another application. Current medications can be produced more quickly and affordably with the aid of modern biotechnology. Bioinformatics is the fastest-growing category. In the context of clinical trials and pharmaceutical research, bioinformatic analysis has taken on a more crucial role. The confluence of biology and data has created a plethora of prospects for better medication development, better research, and better patient outcomes. Knowing which patients will respond to a given cancer treatment, for example, might help clinicians choose the best course of action for their patients. It can also result in tailored therapy and aid in the identification of pharmacological targets. Additionally, biotechnology, forensic analysis, comparative research, evolutionary studies, and veterinary sciences might benefit from the application of bioinformatics.
North America
Asia-Pacific
Europe
South America
Middle East and Africa
North America is the largest growing market. Countries like the United States and Canada are at the forefront. The primary reason for this is the presence of well-established companies. These players have a global presence that increases revenue. Amgen Inc., Gilead Sciences Inc., Biogen Inc., and Vertex Pharmaceuticals Inc. are the prominent ones. These companies have many patents for various drugs in the field of oncology. Enormous investments are made in research and developmental activities due to economic stability. Besides, advanced tools and resources are accessible. Many prestigious universities are involved in biotech studies to decipher concepts. Asia-Pacific is the fastest-growing market. China, Japan, Australia, and South Korea are at the top. Studies revolving around personalized medicine are rapidly growing in these regions. Many startups are coming up with innovative products and technologies. The rising prevalence of chronic conditions has led to the need for better treatments. Governmental support through schemes, training, and funding has helped in the uplift.
COVID-19 Impact Analysis on the Global Biotechnology Market:
The outbreak of the virus had a positive impact on the market. The main way to prevent the containment of the virus was to develop a vaccine. Many clinical trials were conducted by MNCs and startups to come up with a solution. Most of the funding was allotted to healthcare applications. Many organizations increased their budget for research and developmental activities. Numerous studies were conducted to understand the mechanism of action of the virus. Computational tools in biotechnology, also known as bioinformatics, gained popularity. Collaborations and partnerships were prevalent for accelerating treatment and vaccine development. Diagnostic capabilities saw a surge. Telemedicine became the new norm due to lockdowns, movement restrictions, and social isolation. Digital tools like health tracking and monitoring apps gained tremendous emphasis. Global health initiatives saw a drastic rise. Employment opportunities arose in this sector. During the second half of the pandemic, the bioscience sector in the United States employed 2.1 million people, working in over 127,000 U.S. businesses. Post-pandemic, the market has continued to grow owing to demand and interest.
Latest Trends/ Developments:
The advancement of healthcare delivery and patient care is being expedited by the amalgamation of biotechnology and digital health technologies, including artificial intelligence, big data analytics, and telemedicine. Wearable technology, remote monitoring programs, and digital health platforms streamline healthcare procedures, enhance patient outcomes, and enable tailored therapy.
Key Players:
Amgen Inc.
Gilead Sciences, Inc.
Biogen Inc.
Genentech (Roche)
Regeneron Pharmaceuticals Inc.
Moderna Inc.
Vertex Pharmaceuticals, Inc.
CSL Limited
Novozymes A/S
Illumina Inc.
In March 2024, several focused initiatives were proposed by the Commission to advance biotechnology and biomanufacturing within the EU. In keeping with the communication on the long-term competitiveness of the EU, the document on Building the Future with Nature outlines the obstacles and problems and suggests solutions.
In November 2023, at the Bengaluru Tech Summit, the Karnataka government unveiled updated biotechnology and animation, visual effects, gaming, comics, and extended reality (AVGC-XR) policies. This policy emphasizes the application of genomics and genome editing and seeks to establish Karnataka as a global center for clinical trials.
In September 2022, a National Biotechnology and Biomanufacturing Initiative was established by an Executive Order issued by President Biden. This initiative will cut costs for the American people, strengthen supply networks, and generate employment domestically.
Global automotive lighting refers to all vehicle lighting systems, from headlamps that illuminate the road to taillights that communicate movements. They guarantee motorists and other road users alike safety, visibility, and style. While taillights frequently use LEDs for improved visibility, headlights are available in a variety of technologies, including LED and laser. Interior illumination, DRLs, and signal lights all have a role to play. This market, which was estimated to be worth $33.64 billion in 2022, is anticipated to rise to $67.39 billion by 2030 because of laws, luxury tastes, safety concerns, and technological developments like OLED taillights and adaptive headlights. Anticipate a future dominated by intelligent, connected, personalized, and sustainable lighting systems that enhance the safety, efficiency, and aesthetic appeal of automobiles.
Car lighting works its magic to provide safety, visibility, and style. Headlights cut through the night, taillights express intent, and interiors shine with comfort. The billion-dollar global business is expected to rise due to consumer demand for high-end experiences, safer roads, and cutting-edge technology. Imagine dynamic messages being painted by taillights, headlights that adjust to the road, and interiors that customize their atmosphere. Driven by technological advancements like linked systems and laser beams, this future is calling. Anticipate even more visually attractive, environmentally friendly, and intelligent lighting to illuminate the way ahead, making cars safer, more efficient, and unquestionably cooler.
In the market for automobile lighting, safety is the driving force behind demand from the public and laws. While automated high beams smoothly react to traffic, adaptive headlights modify their beams so as not to blind other people. With visually striking displays, dynamic taillights convey intentions for braking and turning. Beyond these developments, integrated pedestrian identification and lane departure alerts will soon make roads safer and brighter for everyone.
Luxurious automobile lighting creates a distinct visual identity that goes beyond simple illumination. Personalized interior lighting customizes the driving experience by setting the mood with a range of colours and intensities, while intricate designs and distinctive DRLs modify exteriors. As you approach your automobile at night, welcoming lights lead the way, resulting in an interior that is perfectly lit. Not only is this symphony of light aesthetically pleasing, but it also stands as a tribute to luxury. Upcoming developments like gesture-controlled lighting and holographic displays promise to further enhance the experience.
The worldwide automotive lighting market is undergoing a significant transition towards energy-efficient solutions, as environmental concerns gain prominence. LED technology is leading the way, providing a ray of hope for the environment and drivers alike. LED lights beam brighter and use a lot less energy than conventional halogen lamps. There are some tangible advantages to this. For drivers, this translates to increased fuel economy, which lowers petrol prices and lessens reliance on fossil fuels. Greater air quality and a reduction in the transport sector's contribution to climate change are the results of reduced overall emissions.
Although the global automotive lighting business is booming, there are still unknowns. Difficulties impede growth even as innovation propels it with eye catching features like laser beams and adaptable headlights. These technologies are luxury items due to their high cost and difficult integration, which puts producers' abilities to the test. The worldwide patchwork created by unclear legislation limits the potential of innovation. Durability issues persist, particularly when complex systems are subjected to challenging conditions. Ultimately, a lot of drivers still don't fully understand how these improvements can help them. Together, we can overcome these obstacles. The keys to reducing costs are improved production, more seamless integration, and unified regulations. Their full potential can be realized by educating customers about the safety, efficiency, and aesthetic value of these lighting wonders. By working together, we can pave the way for an even brighter and safer future for vehicle lighting.
It is made possible by advanced LED technology, which gives drivers the ability to customize their illumination for the highest level of comfort and flair. Consumers that care about the environment want greener products, and vehicle lighting complies. While solar- and self-powered lighting technologies offer a future powered by clean energy, energy-efficient LEDs lower pollution. The advent of connected lighting systems heralds a new age. Envision automobiles interacting with infrastructure and one another to minimize accidents and enhance traffic efficiency. Integrated headlights with pedestrian recognition provide unmatched safety, while dramatic taillights with eye-catching displays alert onlookers to your intentions. The possibilities are endless in the future. Gesture-controlled interior illumination, holographic displays projected onto the road, and even light fixtures with self-healing capabilities.
Due to laws requiring safety features like headlights, taillights, and brake lights, exterior lighting presently holds the most market share in the vehicle lighting industry. The dominance of this market is partly attributed to advancements in safety-focused technologies such as adaptive headlights and daytime running lights. The market value of external lighting is increased by the quick adoption of technology like LED bulbs and laser lights, which improve performance and aesthetics. Conversely, the interior lighting market is expected to increase at the fastest rate in the upcoming years. Innovations like ambient lighting and technology breakthroughs like LED and OLED displays, driven by consumer demand for comfort and personalisation, open new possibilities. The spread of sophisticated interior lighting systems is further driven by the growing emphasis on safety and the expansion of the luxury car market.
The worldwide vehicle lighting market is currently dominated by halogen because of its more affordable price, advanced technology, and useful illumination. With its dependable supply chain and affordable option for manufacturers and cost-conscious customers, halogen holds the biggest market share. The fastest-growing market right now is LEDs, which are predicted to shortly overtake halogen. The rapid expansion of LEDs is driven by their higher efficiency, longer lifespan, flexibility in design, and technological breakthroughs including enhanced brightness. Because LEDs use less energy and produce fewer emissions and better fuel economy, they are becoming more and more popular in the changing automotive lighting market.
Passenger automobiles rule the worldwide automotive lighting market. The sheer number of passenger cars produced which surpasses that of business vehicles and fuels the need for lighting systems is the primary cause of this popularity. The growing demand for personal automobiles in developing nations is a result of rising disposable income, which in turn drives the rise of the passenger car market. The importance that consumers place on safety and aesthetics elements helps to drive market expansion. But in the upcoming years, the market for electric and hybrid cars is expected to develop at the quickest rate. The exponential rise of the worldwide electric car market, which is still expanding and shows no signs of slowing down, is what is driving this surge. Specialised lighting solutions are required since electric and hybrid vehicles have different lighting requirements because of their specific functionality and design aesthetics.
Most lighting systems sold nowadays are sold by OEMs (Original Equipment Manufacturers), primarily because manufacturers pre-install lighting systems in new cars. But in the next years, the aftermarket is expected to develop at the quickest rate. This spike in demand for replacement parts, especially lighting systems, can be linked to several variables, one of them being the average age of cars. The industry is expanding because of consumers' growing desire to personalise their cars with aftermarket lighting upgrades such LED upgrades and decorative lighting. The availability and affordability of technologies like adaptive headlights and laser lights in the aftermarket, together with other advancements in lighting technology, are driving demand even more. Moreover, the growing market for electric cars (EVs).
Throughout the forecast period, Asia Pacific is anticipated to be the automotive lighting market with the highest profitability. Over the past few years, Asia Pacific countries like China and India have seen notable increases in automotive manufacturing and sales, primarily in the medium-to premium luxury car segment. Asia Pacific is predicted to see an increase in the manufacturing of passenger cars, with India experiencing the strongest growth rate. Depending on the state of the national economy, the area offers a suitable selection of both high-end and cheap cars. For instance, there is a substantial demand for halogen, Xenon/HID, and LED since China and India produce more economy and mid-range automobiles. On the other hand, luxury car adoption rates are greater in South Korea and Japan, where LED lighting is the norm.
A brief shadow was thrown by COVID-19 over the worldwide automotive lighting market. Production was stopped by lockdowns and supply chain disruptions, while luxury lighting upgrades were shelved by consumers on a tight budget. Resources became scarce, and R&D stagnated. Still, the market is recovering thanks to resurgent demand and rearranged priorities. While energy-efficient LEDs are being pushed towards adoption by sustainability, safety concerns are driving interest in features like pedestrian detection and adaptive headlights. The digital push of the epidemic creates opportunities for intelligent, networked lighting systems that may interact with infrastructure and other cars. Ultimately, the industry is positioned to shine brighter, focused on safety, sustainability, and a connected future, even though the pandemic dimmed its brilliance.
A development collaboration between OSRAM Continental and REHAU aims to incorporate lighting into external components, providing automobile manufacturers with innovative lighting options that improve functionality and design flexibility. For rear combination lamps, Hella unveiled a revolutionary lighting innovation called Hella FlatLight technology. A Memorandum of Understanding (MoU) was signed by Samvardhana Motherson Automotive Systems Group BV (SMRPBV), a division of Motherson Group, and Marelli Automotive Lighting to investigate a technology collaboration focused on intelligently lighted external body components. Valeo debuted their revolutionary 360° lighting system at the Shanghai Auto Show. This technology surrounds the car with a band of light, projecting instantaneous, clear signs that other drivers can see from a distance. Pedestrians, cyclists, and scooter riders are especially susceptible to these signals
The global biotechnology market was valued at USD 1.5 trillion and is projected to reach a market size of USD 3.53 trillion by the end of 2030. Over the forecast period of 2024–2030, the market is projected to grow at a CAGR of 13%.
Demand for personalized medicine and advancements in gene editing technologies are the main factors propelling the global biotechnology market.
Based on application, the global biotechnology market is segmented into health, food & agriculture, natural resources & environment, industrial processing, bioinformatics, and others.
North America is the most dominant region for the global biotechnology market.
Amgen Inc., Gilead Sciences Inc., and Biogen Inc. are the key players operating in the global biotechnology market.
Joining thousands of companies around the world committed to making the Excellent Business Solutions.
Specify your preferred Countries, Segments, or timeframes
Unlock Country Level Outlook, Trends, Cross-country Comparability, or supply Chain Variations.
Analyst Support
Every order comes with Analyst Support.
Customization
We offer customization to cater your needs to fullest.
Verified Analysis
We value integrity, quality and authenticity the most.
